Walker Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Walker Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,229	Closed	-$209K	–	146
2025 Q1	$209K	Buy	1,229 +3	+0.2%	+$521	0.13%	130
2024 Q4	$204K	Hold	1,226	–	–	0.13%	129
2024 Q3	$211K	Buy	+1,226	New	+$203K	0.13%	131
2024 Q2	–	Sell	-1,359	Closed	-$209K	–	138
2024 Q1	$209K	Sell	1,359 -2	-0.1%	-$305	0.14%	130
2023 Q4	$215K	Buy	+1,361	New	+$196K	0.16%	124
2023 Q3	–	Sell	-1,429	Closed	-$219K	–	92
2023 Q2	$219K	Hold	1,429	–	–	0.18%	84
2023 Q1	$222K	Hold	1,429	–	–	0.19%	84
2022 Q4	$220K	Buy	+1,429	New	+$211K	0.19%	79

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walker Asset Management's FBT Position: Q2 2025 in Review

Walker Asset Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2025, closing a stake of 1,229 shares — an estimated $209K sold.

Walker Asset Management first reported a position in FBT in Q4 2022 and held it in 8 quarters. The position peaked at $222K in Q1 2023. 250 funds tracked by Wall St. Rank hold FBT as of Q2 2025.

Walker Asset Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2025 after selling out during the quarter.
Walker Asset Management sold 1,229 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2025, an estimated $209K.
Walker Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and held it in 8 quarters.
Walker Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $222K in Q1 2023.
250 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2025.

Based on Walker Asset Management's 13F filing for Q2 2025, filed 17 Jul 2025.